GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Yifan Pharmaceutical Co Ltd (SZSE:002019) » Definitions » Pre-Tax Income

Yifan Pharmaceutical Co (SZSE:002019) Pre-Tax Income : ¥-619 Mil (TTM As of Sep. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Yifan Pharmaceutical Co Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Yifan Pharmaceutical Co's pretax income for the three months ended in Sep. 2024 was ¥91 Mil. Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-619 Mil. Yifan Pharmaceutical Co's pretax margin was 7.45%.

During the past 13 years, Yifan Pharmaceutical Co's highest Pretax Margin was 34.99%. The lowest was -21.36%. And the median was 18.68%.


Yifan Pharmaceutical Co Pre-Tax Income Historical Data

The historical data trend for Yifan Pharmaceutical Co's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Yifan Pharmaceutical Co Pre-Tax Income Chart

Yifan Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,068.19 1,080.71 210.79 156.74 -869.03

Yifan Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 31.07 -1,003.80 158.91 134.74 91.41

Competitive Comparison of Yifan Pharmaceutical Co's Pre-Tax Income

For the Drug Manufacturers - General subindustry, Yifan Pharmaceutical Co's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yifan Pharmaceutical Co's Pre-Tax Income Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Yifan Pharmaceutical Co's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Yifan Pharmaceutical Co's Pre-Tax Income falls into.



Yifan Pharmaceutical Co Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Yifan Pharmaceutical Co's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=140.393+0+-75.552+13.129+-947.001
=-869

Yifan Pharmaceutical Co's Pretax Income for the quarter that ended in Sep. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=93.27+0+-19.212+2.713+14.635
=91

Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-619 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yifan Pharmaceutical Co  (SZSE:002019) Pre-Tax Income Explanation

Yifan Pharmaceutical Co's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=91.406/1226.122
=7.45%

During the past 13 years, Yifan Pharmaceutical Co's highest Pretax Margin was 34.99%. The lowest was -21.36%. And the median was 18.68%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Yifan Pharmaceutical Co Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Yifan Pharmaceutical Co's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Yifan Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 50 Qinshan, Jincheng, Lin'an Economic Development Zone, Hangzhou, Zhejiang, CHN, 311300
Yifan Pharmaceutical Co Ltd is a China-based company engaged in R&D and production company focusing on the pharmaceutical and health sectors. Its vision is to develop drugs with definite clinical values, to help disease-afflicted patients regain health. The group focuses on four business areas such as biologics, small molecules, synthetic biologics, and special traditional Chinese medicines (TCMs). The products of the company are Ryzneuta, Plerixafor Injection, Vincristine Sulfate, Skin Allergy Reli, and Others.
Executives
Ye Yi Qun Director
Zhang Da Wei Executives
Geng Yu Hong Executives
Feng De Qi Directors, Directors, and Executives
Zhou Ben Yu Director
Lin Xing Directors, executives
Yu Hai Xia Executives
Cheng Xian Feng Directors, executives
Xu Guo Han Supervisors
Cao Shi Mei Director
Lin Guan Yu Director
Zhang Lian Chun Executives
Guo Xin Fu Director
Zheng Shi Ming Supervisors
Yin Hang Hua Executives

Yifan Pharmaceutical Co Headlines

No Headlines